[시장보고서]세계의 제세동기 시장 규모 : 최종사용자별, 제품별, 지역별, 범위 및 예측

세계의 제세동기 시장 규모 : 최종사용자별, 제품별, 지역별, 범위 및 예측

Global Defibrillators Market Size By End User(Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets), By Product(Implantable Cardioverter Defibrillators (ICDS), External Defibrillators), By Geographic Scope And Forecast

상품코드 : 1623502

리서치사 : Verified Market Research

발행일 : 2024년 09월

페이지 정보 : 영문 202 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,950

￦ 5,703,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 4,850

￦ 7,002,000

PDF & Excel (5 User License)

PDF 및 Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

US $ 7,550

￦ 10,900,000

PDF & Excel (Enterprise User License)

PDF 및 Excel 보고서를 동일기업내 모든 분들이 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.

한글목차

샘플 요청 목록에 추가

제세동기 시장 규모와 예측

제세동기 시장 규모는 2020년에 108억 8,000만 달러로 평가되며, 2021-2028년 CAGR 5.60%로 성장하며, 2028년에는 167억 2,000만 달러에 달할 것으로 예측됩니다.

대상 질환의 위험이 가장 높은 고령 인구 증가, 심장질환 발생률 증가, 공공 접근성 제세동기 제공에 대한 관심 증가는 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 세계의 제세동기 시장 보고서는 시장에 대한 종합적인 평가를 제공합니다. 주요 부문, 동향, 시장 성장 촉진요인, 억제요인, 경쟁 환경, 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석합니다.

제세동기 시장의 정의

제세동기는 무정맥성 심실빈맥, 부정맥, 심실세동과 같은 심각한 상태에서 환자의 심장에 치료용 충격을 가하는 데 사용되는 전자 기기입니다. 전기 충격은 심장 근육을 탈분극시켜 정상적인 전기 자극을 회복시킵니다. 생명을 위협하는 부정맥으로 고통받는 사람들의 갑작스런 죽음을 예방할 수 있습니다. 제세동기의 최종사용자는 병원, 진료소, 심장센터, 예비 병원, 공공 접근 시장, 재택치료, 대체 의료 시장입니다. 제품에 따라 이식형 제세동기(ICD), 체외 제세동기, 수동형 체외 제세동기, 착용형 제세동기(WCD)로 나뉩니다.

세동세계의 제세동기 시장 개요

대상 질환의 위험이 가장 높은 노인 인구 증가와 공공 접근성 제세동기 제공에 대한 관심이 높아짐에 따라 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 또한 제세동기 관련 교육 및 인식 제고 프로그램, 심장질환 발생률 증가는 향후 수년간 제세동기 시장을 촉진할 것으로 예상됩니다. 또한 CRT-Ds, S-ICD, MRI 지원 ICD의 개발이 진행되고 있습니다.

시장 성장을 저해하는 억제요인과 과제들도 존재합니다. 갑작스런 심장마비(SCA)에 대한 인식 부족, 제품 결함 등의 요인이 시장 성장 억제요인으로 작용할 가능성이 높습니다.

개요
북미 지역의 시장 추산·예측, 2012-2025년
- 미국
- 캐나다
- 멕시코
유럽 지역의 시장 추산·예측, 2012-2025년
- 독일
- 영국
- 프랑스
- 기타 유럽
아시아태평양의 시장 추산·예측, 2012-2025년
- 중국
- 일본
- 인도
- 기타 아시아태평양
라틴아메리카 지역의 시장 추산·예측, 2012-2025년
- 브라질
- 아르헨티나
세계의 기타 지역의 시장 추산·예측, 2012-2025년

제8장 세계의 제세동기 시장 경쟁 구도

개요
기업 시장 점유율
벤더 구도
주요 개발 전략

제9장 기업 개요

Medtronic PLC
St. Jude Medical, Inc.
Boston Scientific Corporation
Philips Healthcare
Zoll Medical Corporation
Biotronik Se & Co.Kg
Physio-Control International, Inc.
Cardiac Science Corporation
Sorin Group
Nihon Kohden Corporation

제10장 부록

관련 리포트

KSA

영문 목차

영문목차

Defibrillators Market Size And Forecast

Defibrillators Market size was valued at USD 10.88 Billion in 2020 and is projected to reachUSD 16.72 Billion by 2028, growing at aCAGR of 5.60% from 2021 to 2028.

The growing geriatric population having the highest risk of target diseases, rising incidence of cardiac diseases, and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. The Global Defibrillators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Defibrillators Market Definition

A defibrillator is an electronic device used to deliver a therapeutic shock to a patient's heart in serious conditions like pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock depolarizes the heart muscles and restores its normal electric impulse. It can prevent sudden death among people suffering from life-threatening arrhythmia. End-Users of defibrillators are Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. Based on the product, they are classified into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS).

Global Defibrillators Market Overview

The growing geriatric population having the highest risk of target diseases and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. Also, training & awareness programs on defibrillators and the rising incidence of cardiac diseases expects a boost to the market in the coming years. Additionally, the development of CRT-Ds, S-ICDs, and MRI-compatible ICDs

There are certain restraints and challenges faced which can hinder the market growth. Factors such as lack of awareness about the sudden cardiac arrest (SCA) and product failures are likely to act as market restraints.

Global Defibrillators Market: Segmentation Analysis

The Global Defibrillators Market is Segmented into End User, Product, And Geography.

Defibrillators Market by End-User

Hospitals, Clinics, & Cardiac Centers

Pre-Hospitals

Home Care

Alternate Care Markets

Based on the end-user, the market is bifurcated into Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. The Hospitals, Clinics, & Cardiac Centers segment is predicted to hold the largest market share. The factors can be attributed to the availability of reimbursements facilities and upsurge in the number of cardiac implant procedures.

Defibrillators Market by Product

Implantable Cardioverter Defibrillators (ICDS)

Implantable Cardioverter Defibrillators (T-ICDS)

Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)

Dual-Chamber ICDS

Single-Chamber ICDS

Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

External Defibrillators

Automated External Defibrillators (AEDS)

Semi-Automated External Defibrillators

Fully Automated External Defibrillators

Manual External Defibrillators

Wearable Cardioverter Defibrillators (WCDS)

Based on the product, the market is bifurcated into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS). The Implantable Cardioverter Defibrillators (ICDS) segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) & S-ICD systems across the globe and the development of technologically advanced devices with extended longevity.

Defibrillators Market by Geography

Based on regional analysis, the Global Defibrillators Market is classified into

North America

Europe

Asia Pacific

Rest of the world

The largest share in the market will be dominated by North America owing to the technological advancements, increasing the geriatric population, and the prevalence of cardiac diseases in this region.

Key Players

The Major Players in the market are as follows:

Medtronic PLC
St. Jude Medical, Inc.
Boston Scientific Corporation
Philips Healthcare (A Division of Koninklijke Philips N.V.)
Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
Biotronik Se & Co.Kg
Physio-Control International, Inc.
Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
orin Group (Now Livanova PLC)
Nihon Kohden Corporation

These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Key Developments

Product Launches and Product Expansions

On April 2020, Philips, a health technology company, announced that the Emergency Care and Resuscitation (ECR) business is recommencing the US manufacturing and shipping of external defibrillators. The company notified that the US Food and Drug Administration (FDA) had lifted the restrictions imposed on the manufacturing and distribution of defibrillators in the US.
On March 2021, The Rankin government announced that all public schools in Nova Scotia would be provided automated external defibrillators. The government invested USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.
On July 2021, ZOLL Medical Corporation announced that the company had received clearance from FDA 510(k) to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provided clinical decision support for managing patients with TBI and was available in international markets, but it is now available in the U.S. market with the FDA clearance.

1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 Global Defibrillators Market, By End User

5.1 Hospitals, Clinics, & Cardiac Centers
5.2 Pre-Hospitals
5.3 Public Access Markets
5.4 Home Care
5.5 Alternate Care Markets

6 Global Defibrillators Market, By Product

6.1 Implantable Cardioverter Defibrillators (ICDS)
- 6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
- 6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
- 6.1.1.2 Dual-Chamber ICDS
- 6.1.1.3 Single-Chamber ICDS
- 6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
6.2 External Defibrillators
- 6.2.1 Automated External Defibrillators (AEDS)
- 6.2.1.1 Semi-Automated External Defibrillators
- 6.2.1.2 Fully Automated External Defibrillators
6.3 Manual External Defibrillators
6.4 Wearable Cardioverter Defibrillators (WCDS)

7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
- 7.5.1 Brazil
- 7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 a€" 2025

8 GLOBAL DEFIBRILLATORS MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies

9 COMPANY PROFILES

9.1 Medtronic PLC
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 St. Jude Medical, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Boston Scientific Corporation
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Philips Healthcare
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Zoll Medical Corporation
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Biotronik Se & Co.Kg
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Physio-Control International, Inc.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Cardiac Science Corporation
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Sorin Group
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Nihon Kohden Corporation
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments

10 Appendix

10.1 Related Reports